• WATSON PHARMACEUTICALS INC Financial Overview

  • Income Statement: WPI

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 2.50 B 1.98 B 517.41 M 20.72%
    Gross Profit 815.49 M 582.05 M 233.44 M 28.63%
    Net Income Before Extra Items/Preferred Div 141.03 M -445.00 M 586.04 M 415.54%
    Operating Income 315.84 M 145.97 M 169.87 M 53.78%
  • Cash Flow: WPI

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing -312.50 M 634.77 M -947.28 M 303.13%
    Net Cash Flow - Investing 64.29 M 1.42 B -1.36 B -2,107.77%
    Net Cash Flow/Operating Activities 427.18 M 471.36 M -44.19 M -10.34%
  • Balance Sheet: WPI

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 3.41 B 3.71 B -295.09 M -8.65%
    Total Liabilities 1.56 B 2.02 B -464.16 M -29.74%
    Shareholders Equity 1.85 B 1.68 B 169.08 M 9.14%
  • Key Ratios / Statistics: WPI

    • Valuation

      Price/Earnings (TTM) 21.37
      Price/Sales (TTM) 1.27
      Price/Book (MRQ) 1.44
      Price/Cash Flow (TTM) 7.52
    • Profitability

      Gross Margin 32.66
      Operating Margin 12.65
      Profit Margin 5.65
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.09
      Current Ratio (MRQ) 2.93
      Long Term Debt-to-Equity (MRQ) 41.85
    • Management Effectiveness

      Return on Equity (TTM) 7.73
      Return on Assets (TTM) 5.99
      Return on Investments (TTM) 6.00